1 / 32

Intraoperative Aberrometry

Intraoperative Aberrometry. Mark Packer, MD, FACS Clinical Associate Professor Oregon Health & Sciences University. Abbott Medical Optics, Inc. Advanced Vision Science, Inc. Bausch & Lomb Surgical, Inc. Carl Zeiss Surgical, Inc. Celgene, Inc. GE Healthcare Haag-Streit USA

nellis
Download Presentation

Intraoperative Aberrometry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Intraoperative Aberrometry Mark Packer, MD, FACS Clinical Associate Professor Oregon Health & Sciences University

  2. Abbott Medical Optics, Inc. • Advanced Vision Science, Inc. • Bausch & Lomb Surgical, Inc. • Carl Zeiss Surgical, Inc. • Celgene, Inc. • GE Healthcare • Haag-Streit USA • Ista Pharmaceuticals • LensAR, Inc.* • Rayner Intraocular Lenses, Ltd. • Surgiview LLC* • Transcend Medical, Inc.* • TrueVision Systems, Inc.* • WaveTec Vision Systems* Mark Packer, MDFinancial Disclosure (*stock options) April 1, 2010

  3. Purpose • To determine the effect of intraoperative wavefront-guided enhancement of limbal relaxing incisions on the rate of postoperative excimer laser enhancement

  4. ORange Aberrometer • Talbot moire interferometry • Fourier transform • Calculation of spectacle correction

  5. Methods • Retrospective chart review • Patients having limbal relaxing incisions (LRIs) at the time of cataract or RLE surgery • May 2007 to June 2009 • August 2008  ORange • WaveTec, Inc., Aliso Viejo, CA

  6. Methods • Standardized LRI technique • Sim Ks (EyeSys, Tracey, Inc) • Nichamin nomogram • After IOL insertion (IOP ≥ 25 mm Hg) • 10 mm OZ • Ruminson Astigmatic Gauge and Marker (Rhein Medical, Tampa, FL) • 90% depth • Cornea Gage Plus (Sonogage, Cleveland, OH) • Stealth Triamond (Mastel Precision, Rapid City, SD)

  7. Methods • Enhancement by extending arcs • measured axis ± 15º of expected • (SIA + 0.5 D @ 90º) • residual cylinder ≥ 1.0 D.

  8. Results - Total • 67 eyes of 48 patients • 62.6 ± 9.0 years • Mean pre op ∆K = 1.4 • Mean steep axis = 85º • Mean 10 mm pachy = 674 µ • Post op MR Cyl at 29 days (n = 66) = 0.42 D • Post op MR Cyl at 7 months (n = 34) = 0.59 D

  9. Results – Group 1 • 37 eyes of 27 patients • Not measured with intraoperative aberrometry • 63.5 ± 9.0 years • Mean pre op ∆K = 1.5 D (0.51 – 2.64) • Mean steep axis = 83º • Mean pre op 10 mm pachy = 679 µ • Post op MR Cyl at 33 days (n =36 ) = 0.48 D • Post op MR Cyl at 9 months (n = 20) = 0.53 D

  10. Results – Group 2 Total • 30 eyes of 21 patients • Measured with intraoperative aberrometry • 61.5 ± 9.1 years • Mean pre op ∆K = 1.28 D (0.52 – 3.25) • Mean steep axis = 87º • Mean pre op 10 mm pachy = 668 µ • Post op MR Cyl at 24 days (n = 28) = 0.37 D • Post op MR Cyl at 5 months (n = 14) = 0.41 D

  11. Mean Preoperative Characteristics Group 1 Group 2 p-value Age, years 63.5 61.5 0.34 ∆K, D 1.5 1.28 0.40 Axis, º 83 87 0.21 Pachy, µ 679 668 0.42

  12. Postoperative Characteristics Group 1 Group 2 Mean Sphere -0.27 -0.33 Mean MRSE +0.0 -0.15 Median UCVA 20/25 20/25 MR Cyl 0.48 0.37 ≥ 0.75 D 10 (27%) 7 (23%) ≥ 1.00 D 9 (24%) 2 (6.6%) ≥ 1.25 D 4 (11%) 1 (3.3%)

  13. Group 1: ∆K v MR Cyl

  14. Group 2: ∆K v MR Cyl

  15. Results – Group 2 Enhanced • 8 eyes of 6 patients • Enhanced with extended LRIs • 62.2 ± 12.5 years • Mean pre op ∆K = 1.75 D (0.87 – 3.25) • Mean steep axis = 82º • Mean pre op 10 mm pachy at steep axis = 655 µ • Post op MR Cyl at 29 days (n = 8) = 0.31 D • Post op MR Cyl at 6 months (n = 3) = 0.42 D

  16. Group 2 (LRI enhanced): ∆K v MR Cyl

  17. Results – Laser Enhanced • 7 eyes of 5 patients (7/67 = 10.5%)

  18. Results – Laser Enhanced Without aberrometry (Group 1)  6/37 = 16.2% 59.8 ± 3.7 years Mean pre op ∆K = 1.70 D (0.76 – 2.32) Mean steep axis = 95º Mean 10 mm pachy at steep axis = 664 µ Before excimer at 2 - 11 months MRSE = -0.39 D (-1.1 – 0.38) MR Cyl = 1.45 D (1.0 – 2.5)

  19. Results – Laser Enhanced With aberrometry (Group 2)  1/30 = 3.3% • 58 years • Pre op ∆K = 2.61 D • Steep axis = 78º • Pre op 10 mm pachy at steep axis = 658 µ Before excimer (1 month) MRSE = -0.50 D MR Cyl = 1.00 D

  20. Laser enhanced: ∆K v MR Cyl

  21. Comparison of Enhanced Eyes

  22. Conclusion • Intraoperative wavefront guided enhancement of LRIs reduced the rate of postoperative excimer laser enhancement from 16.2% to 3.3%, an odds ratio of 5.71 (p=0.12).

  23. Conclusion • Small case-control study indicates a trend • Further research (prospective, randomized) indicated to validate effect

More Related